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and adolescents as a risk factor of glucose
homeostasis disturbances and their
complications
Otyłość i nadwaga u dzieci oraz młodzieży jako czynnik ryzyka zaburzeń
homeostazy glukozy i ich powikłań
ABSTRACT
The excessive body mass prevention should be con-
ducted from the first months of the child’s life. The
waist circumference measurement should be obli-
gatorily performed during the routine check-up visits
because some children with abdominal obesity do
not fulfill the body weight or BMI obesity criterion.
Children with positive family history of the
cardiovascular diseases, hypertension, lipid dis-
turbances or diabetes ought to be closely monitor
for the blood pressure, blood lipids and glycemia
abnormalities. (Diabet. Prakt. 2011; 12, 5: 180–187)
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Introduction
Adipose tissue nowadays not only is regarded
as an energy depot but is also recognized as a sour-
ce of endo- and paracrine substances. The fat tissue
is additionally a place where receptors for many
hormones, cytokines, lipoproteins and growth fac-
tors as well as adrenergic receptors occur [1–6].
A change in adipose tissue mass causes
a change in the endocrine function. Leptin and re-
sistin secretion become increased and adiponec-
tin secretion decreases. These alterations affect
other biologically active substances that take part
in important metabolic processes as well (i.e. TNF-a,
IL-6) [7–9].
Retinol binding protein 4 (RBP4) is a novel adi-
pocytokine that may link obesity and insulin resi-
stance. RBP4 is a marker of adipose tissue mass and
obesity already evident in children. The association
of RBP4 with metabolic and cardiovascular sequelae
of obesity appears to be secondary to the underly-
ing relationship with body fat [10].
An opinion is being put forward that insulin
resistance and its related conditions affect people
with abnormal functions of fat tissue which is ter-
med adiposopathy [11].
This adipose tissue disease typically presents
as adipocyte hypertrophy, visceral obesity and ec-
topic fat accumulation in other tissues. In the con-
ditions of positive energetic balance the size of the
cells increases at first which is then followed by
generation of new adipose cells from preadipocy-
tes. If this continues, adipose tissue cells undergo
further hypertrophy with accompanying angioge-
nesis abnormalities. This will escalate fat tissue dys-
function.
Adipose tissue excess can produce a number
of metabolic disturbances in the organism. Because
the increase in adipocyte number is irreversible the
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excessive amount of these cells that develops in the
childhood can result in obesity in the adulthood. For
several years obesity in childhood was considered
as a cosmetic defect only, rather than a health is-
sue. In the eighties of the last century a growing
number of reports about the impact of obesity on
the adolescents’ health were beginning to appear.
One has started to pay attention to its accompany-
ing symptoms like hypertension, dyslipidemia or
glucose tolerance disturbances [12].
At first the observations were made in the po-
pulations with high rate of marked obesity. Subse-
quently it was noted that these kinds of abnormali-
ties are abundant also in other groups of patients
including Caucasian adolescents. It is confirmed also
by some polish studies [13–16].
To assess the excess body weight different
indexes are used. The DEXA method (dual-energy
X-ray absoptiometry) is currently considered a refe-
rence method in the evaluation of the body compo-
sition. It is a low-invasive examination allowing the
assessment of the bone mineral density as well as
lean body mass and body fat [17].
Waist circumference (WC), waist/hip ratio
(WHR) and waist/height ratio (WHtR) are easy in-
direct markers helpful in assessment of the abdo-
minal obesity. The result of waist circumference
measurement in children should be compared with
the existing percentile charts or tables with nor-
mative values that include sex and age. That kind
of standards have been created for polish deve-
lopmental population by Ostrowska-Nawarycz et
al. [18].
The causes of obesity
Three major factors modulate body weight:
metabolic factors, diet, and physical activity, each
influenced by genetic traits.
Genetic factors
Performed international and multicenter stu-
dies allowed to identify 18 new gene loci, which in-
fluence the general obesity and 13 new loci connec-
ted with the adipose tissue distribution. The
published studies throw a light on the reasons why
some people are prone to obesity while some are
not [19].
Similar studies concerning genetic backgro-
und of obesity have been conducted also in chil-
dren [20, 21].
The mentioned issue was also the subject of
Prof Krętowski’s lecture during this year’s PTD (Po-
lish Diabetes Society) meeting [22].
Clinical observations showing higher prevalen-
ce of obesity in children from families with overwe-
ight parents (that are overweight) have led to the
search for obesity gene [23].
It is considered that genetic factors are respon-
sible in 25–45% for the development of obesity.
Environmental factors
The genetic predisposition is overlapped by
very important environmental factors. It is known
that obesity may appear as a result of disturbances
of the genes controlling body mass, however this
factor solely is not sufficient to cause it. In the cir-
cumstances of facilitated food access and limitation
of physical activity the expression of genes respon-
sible for body mass build-up leads to obesity. The
influence of the environment is the strongest in the
childhood when all the alimentary habits are for-
ming. Not only is the ingested calories excess im-
portant but also the incorrect meal composition.
They cause postprandial hyperglycemia(s) which sti-
mulate insulin secretion as well as may lead to the
endothelium damage [24].
Decreased physical activity plays crucial role in
the processes leading directly and indirectly to the
excessive body mass gain. Diminished energetic
expense causes disturbance of the energetic balan-
ce of the organism [25].
Consequences of obesity
Insulin resistance
Obesity and overweight promotes insulin resi-
stance [4, 26]. It particularly applies to the abdomi-
nal obesity which is strongly connected with that
phenomenon [27, 28].
In the visceral adipose tissue adipocyte hy-
pertrophy occurs. Fat accumulation in the liver,
skeletal muscles but also in the kidneys, pancreas
and heart is essential for the development of in-
sulin resistance. In the process of adipocyte hy-
pertrophy a number of alterations promoting li-
polysis emerge which in turn cause an increase of
free fatty acids (FFA) concentration in the blood.
Raised FFA influx decreases insulin sensitivity thro-
ugh the gluconeogenesis augmentation and we-
akening of inhibitory action of insulin on the glu-
cose production in the liver. In the skeletal muscles
a stop in glucose transport to the cells, reduction
of glucose oxidation and glycogen synthesis oc-
curs. Fat accumulation is present also in other or-
gans. In the islets of pancreas, b-cell dysfunction
and disturbed insulin secretion can be found. The
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experimental studies showed that the increased
FFA inflow in kidneys can cause tubulo-interstitial
lesions. Moreover, the accumulation of fat in the
heart may lead to the cardiomyocytes necrosis and
promote contractility disturbances. In the clinical
setting a relationship between insulin resistance
and heart muscle hypertrophy was observed. The
increased accumulation of the adipose tissue in
the perivascular space is also of note. It is consi-
dered that obesity appears in people who have
a genetic predisposition and when a favourable
environmental conditions are present i.e. it has an
epigenetic background. Epidemiological studies
that document different prevalence of insulin re-
sistance in different populations as well as those
revealing familial predisposition(s) to the develop-
ment of disorders connected with it, suggest ge-
netic background. Currently it is considered that
genetic factors are responsible for the develop-
ment of insulin resistance in 46–80% [29].
Low physical activity and high-caloric diet rich
in foods with high glycemic index are regarded main
environmental factors associated with the develop-
ment of insulin resistance. The coexistence of those
factors leads to the increased prevalence of overwe-
ight and obesity [30].
Abnormalities of the fetal development are also
mentioned as one of the environmental factors. In
children born small for gestational age (SGA) com-
pared to those with normal birth weight, insulin re-
sistance and other features of metabolic syndrome
are more frequently observed [31–35].
The precise mechanism of this phenomenon is
not known. A few hypotheses try to explain it ie.
“thrifty fenotype hypothesis”, “foetal insulin hypo-
thesis” or “foetal salvage hypothesis” [36].
On the contrary, children born with abnormal-
ly high birth weight are prone to develop obesity
and insulin resistance as well [37].
Decreased physical activity is an important fac-
tor magnifying insulin resistance [38, 39].
As 70–80% of glucose is utilized in skeletal
muscles they form one of the main effector organs
for the peripheral action of insulin [40].
In skeletal muscles, as results of the studies
show, post receptor signaling disturbances leading
to GLUT4 translocation abnormalities and in effect
causing decreased glucose transport to myocytes are
the main reasons of insulin resistance. Mitochon-
drial defect is also related to the insulin resistance
in muscles. It causes decreased fatty acids oxidation
and accumulation of the intracellular acetyl-CoA and
other toxic products of lipid metabolism (i.e. diacyl-
glycerols and ceramides). Studies performed in chil-
dren display that insulin sensitivity depends on phy-
sical activity with its increase related to the intensi-
ty of the activity. The insulin sensitivity’s
improvement while performing physical activity is
connected to the increased b-oxidation of fatty acids
which in turn leads to the increased lipid turn-over
in myocytes (IMCL intramyocellular lipids) and de-
creased lipid peroxidation.
As one of the outcomes of insulin resistance
the excessive b-cells stimulation leading to endoge-
nous insulin’s over-secretion in order to maintain
glucose homeostasis occurs. A gradual loss of b-cell
mass with glucose tolerance impairment is a result
of this process.
Several indices are used to determine sensitivi-
ty to the action of insulin. The hyperinsulinemic eu-
glycemic metabolic clamp is regarded as “a gold
standard”. Being the most accurate method the
clamp is also complicated and used mostly for expe-
rimental purposes.
In persons with preserved insulin secretion,
much easier indirect methods are used in the popu-
lation based studies. They are based on the relation
between blood insulin and glucose concentrations
in the fasting state or during the oral glucose tole-
rance test (OGTT) [41, 42].
Type 2 diabetes
and metabolic syndrome
Diabetes and glucose tolerance impairment are
the outcomes of insulin resistance. On this basis it is
crucial to perform the glucose concentration asses-
sment as a screening in obese people including chil-
dren and adolescents, especially when other type 2
diabetes risk factors are present. Most of the publi-
shed data come from the studies from outside Eu-
rope [43–52].
However, the increasing number of studies
describing glucose metabolism disturbances in chil-
dren and adolescents with obesity and overweight
have been performed appear in the European coun-
tries [53–56].
The observations made in Polish centers con-
firm these reports [57–60]. Recently published re-
sults of the study in 78 obese children showed hy-
perinsulinemia in 53.8% and the increase of the
R-HOMA index in 62.3% of the study group [60].
Von Berghes et al. [61] point at insulin’s secre-
tion abnormalities in obese children. Kleber et al.
[54] performing a study in a group of 169 obese
European children, after a year of follow-up, reve-
aled impaired glucose tolerance (IGT) in 11.2% and
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impaired fasting glycemia (IFG) in 2.4% of them.
A study conducted by Italian authors in 530 chil-
dren with obesity/overweight the presence of glu-
cose metabolism disturbances in 12.4% of patients,
most commonly IGT — 11.2%. Only in two adole-
scent patients (0.4%) a disorder named “silent
T2DM” was identified. The endogenous insulin’s
concentration and HOMA-IR were higher in patients
with IGT than in subjects with normal glucose tole-
rance. The authors suggest that OGTT may be war-
ranted as the screening test in all obese and over-
weight European children.
Studies performed in Germany in 520 children
with BMI > 97th percentile by Wabitsch et al. [56]
were the impulse to form a conclusion about a need
to diagnose the insulin resistance and glucose ho-
meostasis disturbances also in Caucasian children
that live in Europe.
Insulin resistance plays a role not only in the
development of type 2 diabetes but also in the pa-
thogenesis of other disturbances regarded the com-
ponents of metabolic syndrome [62, 63].
Metabolic syndrome
In the year 2007 IDF introduced the definition
of metabolic syndrome in children which conside-
red three age groups [64].
According to this guidelines metabolic syn-
drome can only be diagnosed in adolescents. It is,
however, underlined that younger children with ab-
dominal obesity and especially with positive fami-
ly history of the insulin resistance relating diseases,
should be regularly tested for the glycemia, lipid
and blood pressure abnormalities [65]. Being re-
garded an important insulin resistance indicator,
the waist circumference criterion was particularly
highlighted [66].
The recent IDF-MS criterion in children repre-
sents a more severe definition and appears to identi-
fy a group of children with higher fasting insulin than
the adapted-MS definition which uses age-related
thresholds (90th percentile). It is urgent to establish
a consensus on MS definition to allow early identifi-
cation of adolescents at risk and the development of
prospective studies to define what cut-offs are the
best indicators of future morbidity [67, 68].
Long-term survivors of childhood cancer ap-
pear to have an increased risk for the metabolic syn-
drome, subsequent type 2 diabetes and cardiova-
scular disease in adulthood compared to healthy
children [69, 70].
The rise in the prevalence rates of overweight
and obesity may explain the emergence of nonalco-
holic fatty liver disease (NAFLD) as the leading cause
of liver disease in pediatric populations worldwide.
NAFLD is closely associated with abdominal
obesity, atherogenic dyslipidemia, hypertension, in-
sulin resistance and impaired glucose tolerance,
which are all features of the metabolic syndrome
[71–73].
Insulin resistance in type 1 diabetes
Because of the proved contribution of the in-
sulin resistance also in type 1 diabetes the current
division into two main types of diabetes is now be-
ing questioned [52, 74–76].
Wilkin [77] in his hypothesis formed an opi-
nion about both types of diabetes being the same
disease differing only in the rate of b-cell function
loss and the underlying mechanisms responsible for
it. Insulin resistance is one of them. The b-cell apop-
tosis is significantly increased by the autoimmune
destruction of the islets of pancreas.
The role of obesity in diabetes type 1
It was formerly considered that the developing
insulin deficit resulting from the progressing b-cell
auto-destruction is the essence of type 1 diabetes.
The insulin sensitivity was regarded intact. Curren-
tly it is known that even in diabetes type 1 insulin
resistance occurs [78].
It is connected with various factors including
the stage of onthologic development as during the
adolescence period a “physiologic insulin resistan-
ce” appears. Overweight plays also a role in the in-
crease of insulin resistance in those patients. In per-
sons with type 1 diabetes the prevalence of
overweight is growing. It results from the aspira-
tion of the patients to acquire better glycemia con-
trol with increasing the dose of insulin instead of
dietary limitations and the physical activity.
According to the “overload hypothesis” the
insulin resistance leads to the overproduction of in-
sulin which in turn stimulates the cellular antigens
expression. It induces the autoimmune processes and
together with augmented apoptosis cause the de-
struction of b-cells [79].
On the other hand insulin resistance overlapping
the decreased insulin secretion can directly accelerate
the onset of type 1 diabetes. Since, the accompanying
resistance to insulin’s action is an additional factor di-
srupting the glucose homeostasis. Nowadays the in-
sulin sensitivity abnormalities in patients with type 1
diabetes are being observed more frequently than
before [78]. It is the rationale to diagnose “double
diabetes” in those patients [80].
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The role of obesity in triggering processes le-
ading to diabetes type 1 onset is lately being paid
more attention to. The importance of insulin resi-
stance in starting the autoimmune processes was
highlighted by Wilkin [81].
Insulin resistance being regarded one of the
possible factors accelerating the clinical revelation
of diabetes may be responsible for increasing mor-
bidity of type 1 diabetes in progressively younger
age groups [82, 83].
Other authors pointed out the role of overwe-
ight during the first period of child’s life in increasing
the risk of acceleration of the autoimmune processes
and the risk of type 1 diabetes development [84].
The extensive review of the results of multi-
center studies about obesity as type 1 diabetes risk
factor in children was recently shown by Verbeeten
et al. [85].
The other authors also underline the signifi-
cant role of overweight and insulin resistance in the
development of diabetes type 1 [86, 87].
Knerr et al. [83] presented a comprehensive
study about the role of overweight in acceleration
of type 1 diabetes occurrence in children. The au-
thors performed an analysis in a group of 9,248
patients from 116 centers in Austria and Germany.
(While) Not all authors are in agreement with the
increase of body weight being the accelerator in dia-
betes (including type 1 diabetes) [88]. This issue re-
mains under discussion [86, 89].
Although overweight is one of the basic fac-
tors leading to the development of type 2 diabetes,
it is not neutral for the patients with type 1 diabe-
tes [78, 90].
The primary cause in this case is the autoim-
mune destruction of the b-cells of pancreas. The sub-
stitution with exogenous insulin preparations is the
cornerstone of the treatment. The increase of adi-
pose tissue mass leads to insulin resistance also in
these patients. Hence it is crucial to maintain the
appropriate body mass by means of proper diet and
physical activity in type 1 diabetes as well. Overwe-
ight in type 1 diabetes patients is frequently the
outcome of hyperinsulinism resulting from chronic
insulin overdosing. The patients try to keep near
normoglycemia by increasing the doses of insulin.
It creates the vicious circle. Insulin dosage increase
without calories restriction leads to the adipose tis-
sue expansion which in turn magnifies the insulin
resistance. The augmented insulin resistance produ-
ces a need for further rise in insulin dose. To break
this vicious circle one needs to reorganize their nu-
trition and the whole daily routine. Restrictions in
the amount of calories intake and the energy expense




As a result of persistent chronic hyperglycemia
a non-enzymatic protein glycation increase and sub-
sequent AGEs (advanced glycation end products)
accumulation can be observed. These processes pro-
duce a number of endothelium disturbances cau-
sing arterial stiffness which leads to the elevation
of systolic blood pressure. In the course of hyper-
glycemia an increased activity of renin-angiotensin-
aldosterone system is observed also leading to the
rise in blood pressure. Insulin resistance plays an
important role in the development of angiopathy in
patients with carbohydrate metabolism disturban-
ces as well [93].
Thickening of the intima-media complex of the
carotid artery is a risk factor for the development of
lesions in the cardiovascular system. Hypertension can
be a sign of changes in this system but one should
remember that even very slight blood pressure eleva-
tion can already be a signal of abnormalities [94].
The values of blood pressure in the area of up-
per normative value for age require a thorough ana-
lysis and usually introduction of treatment. The blo-
od pressure measurement in children needs to be
performed with a high degree of precision and its
result should be referred to the percentile charts [95].
Interpreting the blood pressure measurement
results one should take into account not only the
age, sex and height but also the body weight if the
anthropometric data exceed 90th percentile for age.
Pietrzak et al. [96] presented a study in adolescent
patients with type 1 diabetes which pointed at an
association of the blood pressure values with BMI
and the percentage of body fat.
The results of the studies in adolescents with
diabetes type 1 presented by Dutch authors sho-
wed significant increase of the cardiovascular risk
factors in patients with overweight or obesity com-
pared to those with appropriate body mass [97].
English authors performed an analysis of the
late outcomes of obesity in children. They found that
the presence of overweight and obesity during chil-
dhood and adolescence significantly increases mor-
bidity during adulthood [98].
Epidemiological studies
Because of the dangers that obesity brings all
over the world epidemiological studies are perfor-
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med to determine the scale of that phenomenon
[99, 100].
Poland is also one of the sites of a large-scale
studies on this issue. The developmental population
is being studied among others as the aim of the
OLAF program [101–105].
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